2026年位元堂历年年报/社会责任报告/ESG报告合集（共19套打包）

1、Content 目錄Content 目錄CORPORATE INFORMATION公司資料2INTERIM DIVIDEND中期股息5MANAGEMENT DISCUSSION AND ANALYSIS管理層討論及分析5DISCLOSURE OF INTERESTS權益披露14SHARE OPTION SCHEME購股權計劃20CORPORATE GOVERNANCE AND OTHER INF。

2、According to authoritative market research reports,Wai Yuen Tong is widely recognized as the leading brand offering the best quality Chinese medicine among various brands in the sector.Contents 目錄COR。

3、Content 目錄Content 目錄CORPORATE INFORMATION公司資料2INTERIM DIVIDEND中期股息5MANAGEMENT DISCUSSION AND ANALYSIS管理層討論及分析5DISCLOSURE OF INTERESTS權益披露14SHARE OPTION SCHEME購股權計劃20CORPORATE GOVERNANCE AND OTHER INF。

4、C176382CMYCMMYCYCMYKai172127782617_Wai Yuen Tong AR2024 Cover V03_14mm OP.pdf 1 18/7/2024 下午12:43CMYCMMYCYCMYKai172128717130_Wai Yuen Tong AR2024 IFC V03 OP2.pdf 1 18/7/2024 下午3:19位元堂藥業控股有限公司 二零二四年年報。

5、Contents目錄2Corporate Information公司資料4Interim Dividend中期股息4Management Discussion and Analysis管理層討論及分析20Disclosure of Interests權益披露25Share Option Schemes購股權計劃30Corporate Governance and Other Informatio。

6、*According to Ipsos market survey on consumers of Chinese health supplement products conducted in April 2023*根據Ipsos 益普索2023年4月中式保健品消費者市場調查結果1位元堂藥業控股有限公司二零二三年年報2Corporate Information公司資料5Awards獎項6Cha。

7、Contents目錄Corporate Information公司資料2Interim Dividend中期股息4Management Discussion and Analysis管理層討論及分析4Disclosure of Interests權益披露23Share Option Scheme購股權計劃28Corporate Governance and Other Information企業。

8、C127090股份代號:897位元堂藥業控股有限公司於百慕達註冊成立之有限公司Incorporated in Bermuda with limited liabilityWai Yuen Tong Medicine Holdings LimitedStock CodeContents目錄2Corporate Information公司資料4Awards獎項6Chairmans Statement。

9、位元堂藥業控股有限公司於百慕達註冊成立之有限公司Incorporated in Bermuda with limited liabilityWai Yuen Tong Medicine Holdings Limited股份代號:897Stock CodeInterim Report中期報告Interim ReportC.hkWai Yuen Tong Medicine Holdings Limi。

10、ENVIRONMENTAL,SOCIAL ANDGOVERNANCE REPORT環境，社會及管治報告Contents 目錄ABOUT THE GROUP關於本集團2ABOUT THE REPORT關於本報告3STAKEHOLDER ENGAGEMENT持份者溝通8JOURNEY TO CARBON NET ZERO邁向碳淨零之路12PEOPLE ORIENTED以人為本25OPERATIONA。

11、Annual Report|年報2Corporate Information公司資料4Awards獎項6Chairmans Statement主席報告14Management Discussion and Analysis管理層討論及分析38Board of Directors and Senior Management董事會及高級管理層42Corporate Governance Report。

12、位元堂藥業控股有限公司 二零二四年環境、社會及管治報告12About the Group 關於本集團3About the Report 關於本報告8Stakeholder Engagement 持份者溝通12Journey to Carbon Net Zero 邁向碳淨零之路23People Oriented 以人為本Contents目錄28Operational Excellence 卓越營運。

13、Contents目錄2 Corporate Information 公司資料4 Interim Dividend 中期股息4 Management Discussion and Analysis 管理層討論及分析20 Disclosure of Interests 權益披露24 Share Option Scheme 購股權計劃26 Corporate Governance and Other 。

14、1位元堂藥業控股有限公司二零二三年環境、社會及管治報告2About the Group關於本集團3About the Report關於本報告8Our ESG Governance Structure環境、社會及管治管理架構10Stakeholder Engagement持份者溝通12Materiality Assessment重要性評估13Message from the Board董事會寄語1。

15、Contents目錄2 Corporate Information 公司資料4 Awards 獎項6 Chairman s Statement 主席報告14 Management Discussion and Analysis 管理層討論及分析34 Board of Directors and Senior Management 董事會及高級管理層40 Environmental,Social 。

16、股份代號:897位元堂藥業控股有限公司於百慕達註冊成立之有限公司Incorporated in Bermuda with limited liabilityWai Yuen Tong Medicine Holdings LimitedStock CodeEnvironmental,Social andGovernance Report1位元堂藥業控股有限公司 二零二二年環境、社會及管治報告Con。

17、Contents目錄2 Corporate Information 公司資料4 Interim Dividend 中期股息4 Management Discussion and Analysis 管理層討論及分析15 Disclosure of Interests 權益披露19 Share Option Scheme 購股權計劃21 Corporate Governance and Other 。

18、Environmental,Social and Governance Report|環境、社會及管治報告2About the Group關於本集團3About the Report關於本報告6Sustainability Performance Overview可持續發展績效一覽7Message from the Board董事會寄語8Sustainability Governance可持續發。

19、2Corporate Information公司資料4Awards獎項6Chairmans Statement主席報告12Management Discussion and Analysis管理層討論及分析28Board of Directors and Senior Management董事會及高級管理層34Environmental,Social and Governance Report環。